Video

David Hafler, MD

Publish date: March 6, 2017

Dr. Hafler explains the impact of sodium on multiple sclerosis.


 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Rituximab May Have Advantages Over Fingolimod and Natalizumab in MS
MDedge Neurology
High-risk relatives of MS patients show early signs of disease
MDedge Neurology
Switch from fingolimod to alemtuzumab might trigger MS relapse
MDedge Neurology
New report highlights gaps in knowledge on marijuana use
MDedge Neurology
Treatment Reduces Risk of Long-Term Disability in MS
MDedge Neurology
Ocrelizumab Reduces Disease Progression in MS
MDedge Neurology
Humira Pen topped per-person drug spending in 2016
MDedge Neurology
Relatives of Patients With MS Show Early Signs of Disease
MDedge Neurology
Switch From Fingolimod to Alemtuzumab Might Trigger MS Relapse
MDedge Neurology
How to Treat Pediatric MS
MDedge Neurology